Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Cost-effectiveness of a Lifestyle Intervention to Reduce Cardiometabolic Risk Factors in Individuals With Obsessive-compulsive Disorder: A Randomized Controlled Trial

NCT07206212 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT07206212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07206212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Cost-effectiveness of a Lifestyle Intervention to Reduce Cardiometabolic Risk Factors in Individuals With Obsessive-compulsive Disorder: A Randomized Controlled Trial
Lead sponsor
Karolinska Institutet
Phase
Not applicable
Overall status
Recruiting
Start date
January 30, 2026
Completion date
November 1, 2028
Enrollment
108 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lifestyle (sedentary behavior and physical activity), obsessive compulsive disorder (ocd)